called the premature coronary artery disease. 1 In some studies in Iran, the prevalence of premature coronary heart disease has been even higher. In Vahdat et al. 2 survey on population 25-60 years, the prevalence of premature coronary heart disease was estimated to be 12.6%. In a comprehensive study based on database for cardiac surgeries in Tehran Heart Center in 2007 and with the review of 13 222 case records registered in this database, the frequency of patients aged lower than 40 years and undergoing coronary artery bypass surgery was up to 3.1%. 3 In another study at this center in 2009 and among 2028 patients with angiographic involvement of coronary arteries, 5.4% patients were younger than 40 years. 4 The pointed studies have emphasized the need to further investigate the causes of premature coronary heart disease, especially in our young community. It is also obvious that the occurrence of premature coronary heart disease can be influenced by genetic factors more than by environmental factors. In general, although the frequency of premature coronary heart disease may not appear significant, but given the major role of younger age group in social and economic activities and also possibility of developing adverse effects of the disease at later ages, addressing cardiovascular risk factors in this age group is critical. On the other hand, recent studies have shown that genetic factors predisposing to coronary artery disease in this age group may be different from other age groups because the occurrence of this disease at early ages is unusual. 5, 6 Based on the approved role of genetic factors (mutations or polymorphisms) in the incidence of coronary artery atherosclerosis and also the important role of platelets and atherosclerotic plaque vulnerability in the initiation and progression of this process to the acute myocardial infarction, it is necessary to reveal the genetic basis associated with platelet dysfunction and atheroma plaque vulnerability leading to acute myocardial infarction in these patients, especially in lower ages.
According to recent evidences, a number of matrix metalloproteinase (MMP) gene polymorphisms have been identified which may be probably related to the occurrence of myocardial infarction.
According to the large Framingham cohort study, increased plasma levels of MMP-9 were associated with increased left ventricular dimensions and increased wall thickness, and also with left ventricular remodeling. 7 It has been also demonstrated that MMP-9 gene contribute to plaque formation and expansion by facilitating smooth muscle cell migration and proliferation, and thus, the overexpression of enzymes encoded and produced by this gene may result in weakening of the plaque's fibrous cap, plaque rupture, and finally occurring myocardial ischemic events. 8, 9 Two of the main MMP-9
gene polymorphisms that their roles were taken into consideration are exon-6 R279Q A/G polymorphism and C1562T polymorphism located in -1562 in the promoter region of the gene; however, there is little evidence about the role of this polymorphism in triggering myocardial infarction among patients with coronary artery disease.
This study thus aimed to assess the relationship between these two polymorphisms of the MMP-9 gene and occurrence of myocardial infarction in a large sample of Iranian patients with premature coronary artery disease. Moreover, left ventricular ejection fraction and the number of involved coronary vessels were determined based on angiography results.
| MATERIALS AND METHODS

| Study population
| Genetic variables and genotyping
The single nucleotide polymorphisms (SNPs) evaluated in this study out by employing specific designed primers (Table 1) digested by restriction enzyme Sma I (for R279Q) and primers digested by restriction enzyme Sph I (for C1562T; Figure 1 ). The digested products were then visualized on 3% agarose gel stained with ethidium bromide. After determining the patterns of the polymorphism genotypes by PCR-RFLP technique, the high-resolution melting (HRM) technique was then used for genotyping all study samples. In the present study, the patterns of the genotypes of each sample were determined as wild, heterozygous, or mutant by HRM technique using specific primers (Table 1) by Rotor-Gene 6000 (Corbett Life Science, Santa Clara, CA, USA; Figure 2 ). To finally draft the determined genotypes of the SNPs in RFLP, DNA sequencing was performed in 30 samples in each SNPs.
In final step and to examine the relationship of polymorphism with the serum level of gene product, the serum level of human matrix metalloproteinase 9/gelatinase B was measured using ELISA kit (Cusabio, Wuhan Hi-tech, Wuhan, China).
| Follow-up data
Given the two conditions of patients residing in Tehran and also faced with their first episode of MI, 640 of 1000 study samples that had been previously followed up with a median follow-up time of 
| Statistical analysis
For statistical analysis, results were presented as mean±standard deviation (SD) for median (1st, 3rd quartiles) for quantitative variables and were summarized by frequency (percentage) for categorical variables.
Continuous variables were compared using t test or Mann-Whitney U test whenever the data did not appear to have normal distribution or when the assumption of equal variances was violated across the study groups. Categorical variables were, on the other hand, compared using chi-square test or the Fisher's exact test if required (when <20% of expected frequencies were ≤5). The Cox proportional hazard model was used to analyze the association between the existence of gene polymorphism and total MACE in both MI and non-MI groups, and the hazard ratios were then displayed. Survival was assessed using
Kaplan-Meier curve analysis. P values of ≤.05 were considered statistically significant. For the statistical analysis, the statistical software SPSS version 20.0 for windows (IBM, Armonk, NY, USA) was used. Forward primer 5′-GTAATCCTAGCACTTTGGG -3′
| RESULTS
Reverse primer 5′-TTCACCTTCTTCAAAGCC -3′
HRM technique (for R279Q)
Forward primer 5′-GAGAAATGATGAGAGATGGGATGA -3′
Reverse primer 5′-CCTGAGGACCAATGAGAGTG -3′
HRM technique (for C1562T)
Forward primer 5′-AATTATCTCCATCTCACAGTCTCAT -3′
Reverse primer 5′-CAATTATCACACTTATGCCAAGCCT -3′
F I G U R E 1 PCR-RFLP analysis with Sma I of R279Q polymorphism (A) and with Sph I of C1562T polymorphism (B) to determine polymorphism variants
in MI group were mostly male and younger than non-MI patients. According to retrospective review of findings on follow-up of 640 of all studied patients, the two MI and non-MI groups were followed up for median times of 44.55 months and 46.92 months, respectively, to assess the difference in total MACE-free survival rate across the different genotypes of R279Q and C1562T polymorphisms ( Figure 3 ). Table 3 ).
| DISCUSSION
In clinical settings, the main purpose of the gene association studies is to examine whether single-locus alleles or genotype frequencies differ across disease subgroups to show the critical role of the specific allele or genotype as a risk factor for the disease. In this regard, SNPs are forms of genetic variations in the human genome leading point mutations associated with change in base pair sequences.
This change may result in a new phenotypic condition or even in a disease. Hence, designing case-control studies help to assess these SNPs and their roles in both occurrence of disease and also to determine SNPs roles in predicting outcome of disease. The present study formed as a case-control study to assess first the association between two C1562T and R279Q SNPs of the MMP-9 gene and occurrence of early MI in patients with premature CAD. We also assessed the role of these SNPs to predict long-term outcome of premature CAD in both MI and non-MI groups. In first step and by comparing T A B L E 2 Baseline characteristics and clinical data in both MI and non-MI groups frequencies of the genotypes of the SNPs between MI and non-MI groups, we could show significant differences in the genotype frequencies between these two patients' groups indicating the role of both SNPs to predispose the patients to occurring MI. In addition, measuring the level of MMP-9 gene product in these groups showed higher level of this product (human matrix metalloproteinase 9/gelatinase B) in MI group than in non-MI group. Reviewing the similar studies in other populations (Table 3) shows contradictory results regarding association of C1562T and R279Q SNPs and occurrence of MI in patients with CAD emphasizing the fact that our study for the first time focused on a special subgroup of CAD patients with premature nature of the disease. [10] [11] [12] [13] [14] [15] [16] [17] These different results may be due to some reasons including demographic and ethnic differences, how to design and implement the study in terms of inclusion and exclusion criteria, the sample size used affecting the study power as (Table 4) , it can be concluded that the positive association between MMP-9 C-1562T polymorphism and risk for MI is prominently revealed in
Chinese ethnicity with the different patterns in both European and
Persian ethnicities. Regarding association between MMP-9 R279Q
polymorphism and risk for MI, a few studies are available to achieve a sound and decisive judgment for association between risk of MI and the polymorphism.
In this study, we could show about three-and 16-fold increased risk of MI in premature CAD groups with R279Q and C1562T SNPs,
respectively. This risk pattern was demonstrated in multivariable shown by Saedi et al. 12 on a similar study population by with a small T A B L E 3 Cox proportional hazard modeling for assessing the value of MMP-9 gene polymorphisms for predicting long-term MACE T A B L E 4 Review of the literature on association between R279Q and 1565C/T polymorphisms and occurrence of myocardial infarction in patients with coronary artery disease study sample, MMP-9 was associated with increased risk of developing premature CAD. Koh et al. 15 showed that the C1562T polymorphism had a significant and independent role in the development of acute MI due to plaque rupture in the Korean population. Zhang et al. 17 also revealed that the C1562T polymorphism was associated with complicated coronary lesions. Besides, in a limited number of studies, the association between R279Q and occurrence of acute MI was demonstrated. Horne et al. 20 showed that those CAD group with R279Q polymorphism faced higher risk for MI that the obtained association remained strengthened after full adjustment for baseline confounders. However, the studies by Wang and Opstad could not contrarily demonstrate this association. In total, our findings suggested that the C1562T and R279Q SNPs of MMP-9 gene might increase the risk for developing MI in patients with premature CAD.
The main role of MMP-9 gene polymorphisms is mainly to remodel the extracellular matrix leading to atherosclerotic plaques.
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Different types of gelatinases or MMPs have main situation as composition of the vasculature and are broader substrate specificity for type IV collagen, elastin, aggrecan, and vitronectin. 22 The expression of MMPs genes is affected by myocardial ischemia. It has been well demonstrated that MMP-9 can be upregulated within 24 hours of MI and that this rise was accompanied by a reduction in the physiological inhibitor of MMP-9. 23, 24 Several investigators have also indicated that MMP-9 is expressed within minutes of myocardial ischemia. 25 Thus, overexpression of MMP-9 by initiating ischemic and atherosclerotic processes is expected. Also, increasing MMP-9 in infracted zone after ischemic event is expected.
Although we could not demonstrate the association of MMP-9 polymorphisms and outcome of CAD, some evidences are available T allele of the 1562 C/T polymorphism could increase the risk for long-term cardiovascular events probably mediated through elevated MMP-9 serum concentration. However, it was contrary to our observations, which might be due to the ethnical differences that affect the regulatory pathways of MMP-9 functioning.
| CONCLUSION
In summary, the present association study suggests that C1562T and R279Q SNPs of MMP-9 gene can be associated with the susceptibility to MI in patients with premature CAD. In this regard, the C1562T
and R279Q allele carriers may be at high risk for development of MI in these patients. However, these polymorphisms may not be able to predict long-term cardiac events in these patients.
